AzurRx BioPharma AZRX shares are trading higher after the company announced it will acquire First Wave Bio.
AzurRx BioPharma's stock has been rising Tuesday, up 3.66% to a price of $4.25. The stock's volume is currently 11.06 million, which is roughly 1510.74% of its recent 30-day volume average of 732.10 thousand.
The 50-day moving average price of AzurRx BioPharma's stock was $0.71 when this article was published. The stock reached a high of $5.5 and a low of $0.52 in the past 52 weeks.
Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.